BioMarin Pharmaceutical Inc. and Inozyme Pharma, Inc. announced that BioMarin has entered into a definitive agreement to acquire Inozyme for $4.00 per share in an all-cash transaction for a total ...

EMA’s ETF recommends updating Covid-19 vaccines to target new LP.8.1 variant: Amsterdam, The Netherlands Monday, May 19, 2025, 10:00 Hrs [IST] European Medicines Agency’s (EMA ...

Indian Pharmaceutical Congress 2025 calls for registration of participants under four categories: Our Bureau, Bengaluru Monday, May 19, 2025, 09:00 Hrs [IST] The 74th Indian Pharm ...

PCI may add Pharm D as a qualification for appointment of Registrar of State Pharmacy Councils: Gireesh Babu, New Delhi ...

SEC recommends to upgrade Corbevax from restricted use in emergency situation to new drug: Gireesh Babu, New Delhi Monday, ...

Healthcare sector convinced on precision testing and tech-led monitoring changing medical treatment landscape: Nandita Vijayasimha, Bengaluru Monday, May 19, 2025, 08:00 Hrs [IST] ...

Medical centres in India emphase on protection of sensitive patient data as top priority: Nandita Vijayasimha, Bengaluru Monday, May 19, 2025, 08:00 Hrs [IST] Medical centres in t ...

LUB asks Centre to constitute Drug Tribunal Board to address industry grievances: Peethaambaran Kunnathoor, Chennai Monday, May 19, 2025, 08:00 Hrs [IST] The Laghu Udyog Bharati ( ...